A detailed history of Delaney Dennis R transactions in Abb Vie Inc. stock. As of the latest transaction made, Delaney Dennis R holds 15,412 shares of ABBV stock, worth $3.1 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares
15,412
Previous 15,412 -0.0%
Holding current value
$3.1 Million
Previous $2.81 Million 5.81%
% of portfolio
1.44%
Previous 1.54%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $5,504 - $6,198
-40 Reduced 0.26%
15,412 $2.39 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $5,343 - $6,186
-40 Reduced 0.26%
15,452 $2.3 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $621,736 - $773,710
4,692 Added 43.44%
15,492 $2.09 Million
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $57,844 - $66,616
400 Added 3.85%
10,800 $1.72 Million
Q3 2022

Nov 08, 2022

SELL
$134.21 - $153.93 $342,235 - $392,521
-2,550 Reduced 19.69%
10,400 $1.4 Million
Q2 2020

Jul 28, 2020

SELL
$73.37 - $98.18 $14,674 - $19,636
-200 Reduced 1.52%
12,950 $1.27 Million
Q1 2020

May 07, 2020

SELL
$64.5 - $97.79 $6,450 - $9,779
-100 Reduced 0.75%
13,150 $1 Million
Q2 2019

Jul 24, 2019

SELL
$65.7 - $83.98 $16,425 - $20,995
-250 Reduced 1.85%
13,250 $964,000
Q1 2019

Apr 29, 2019

SELL
$77.14 - $90.79 $19,285 - $22,697
-250 Reduced 1.82%
13,500 $1.09 Million
Q3 2018

Oct 15, 2018

SELL
$88.91 - $98.84 $155,592 - $172,970
-1,750 Reduced 11.29%
13,750 $1.3 Million
Q2 2018

Jul 30, 2018

SELL
$89.78 - $106.23 $127,936 - $151,377
-1,425 Reduced 8.42%
15,500 $1.44 Million
Q1 2018

Apr 24, 2018

SELL
$92.01 - $123.21 $37,724 - $50,516
-410 Reduced 2.37%
16,925 $1.6 Million
Q4 2017

Feb 02, 2018

BUY
$89.56 - $98.21 $1.55 Million - $1.7 Million
17,335
17,335 $1.68 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $356B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Delaney Dennis R Portfolio

Follow Delaney Dennis R and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delaney Dennis R, based on Form 13F filings with the SEC.

News

Stay updated on Delaney Dennis R with notifications on news.